Adenosine and the nervous system: clinical implications

Clinical Neuropharmacology
R GuieuH Rochat

Abstract

After a review of the metabolism and pharmacology of adenosine, this work will examine the various therapeutic possibilities involving the use of agonists or antagonists of adenosine A1 or A2 receptors in neurological disorders. Promising preclinical results have been obtained with epilepsy, cerebral ischemia, alcoholism, and pain.

Citations

Feb 13, 1999·European Journal of Pharmacology·D K Von Lubitz
Jun 4, 1999·European Journal of Pharmacology·D K von Lubitz
Dec 28, 1999·Brain Research. Brain Research Reviews·J L Moreau, G Huber
Jul 17, 1999·Brain Research. Molecular Brain Research·C M AndersonF E Parkinson
Jun 10, 2000·Journal of Clinical Pharmacy and Therapeutics·S AkhondzadehA Kamalipour
Jun 2, 2012·Mens Sana Monographs·Avinash De Sousa, Gurvinder Kalra
Dec 22, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Samarand SalimiShahin Akhondzadeh
Mar 14, 2007·Archives of Medical Research·Mansoureh ToghaSoodeh Razeghi
Feb 8, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shahin AkhondzadehHomayoun Amini
Jul 20, 2018·Neurotoxicity Research·Dongxing WangXia Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.